A new study hints at the cure potential for an intrauterine contraceptive device (IUD) to treat young women with early stage endometrial cancer without compromising their fertility.
Results from the prospective study, carried out by researchers at the European Institute of Oncology in Italy, showed that almost 60 percent of the women with well-differentiated endometrial cancer had a complete response to a treatment that included the implanting of an IUD that contains the progestin levonorgestrel followed by six months of gonadotropin-releasing hormone therapy.
This presents the potential for a much more appealing treatment than a hysterectomy.
Endometrial cancer is the sixth most common cancer among women worldwide, with about 290,000 new diagnoses every year.
CANCER TYPE(S)
Endometrial cancer
TREATMENT TYPE(S)
Intrauterine contraceptive device
WHERE WAS THIS STUDY PUBLISHED?
Annals of Oncology
Source
MedPageToday
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
